Medivir AB (publ)
Research Medivir AB (publ) (MVR0) on Bullrun: market cap EUR 60.22M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerMVR0
- ExchangeF
- CountrySweden
- SectorHealthcare
- IndustryBiotechnology
- CurrencyEUR
- Market capEUR 60.22M
- Financial periodFY2024
- Net income-SEK 123.32M
- Free cash flow-SEK 124.19M
Valuation Snapshot
latest market cap is EUR 60.22M.
About Medivir AB (publ)
Medivir AB (publ), a pharmaceutical company, focuses on the development and commercialization of medical treatments in areas of high unmet medical need in Sweden, the Nordic region, the rest of Europe, and internationally. The company offers Xerclear (Zoviduo), a combination of a polymerase inhibitor and hydrocortisone for the treatment of labial herpes; and Olysio (simeprevir), a protease inhibitor for the treatment of hepatitis C.
Frequently asked questions
What is Medivir AB (publ)'s market cap?
Medivir AB (publ)'s market capitalization is EUR 60.22M.
What does Medivir AB (publ) do?
Medivir AB (publ), a pharmaceutical company, focuses on the development and commercialization of medical treatments in areas of high unmet medical need in Sweden, the Nordic region, the rest of Europe, and internationally.